Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BrosMed Medical

Request full access

Vascular intervention medical device developer

Dongguan, ChinaFounded 2012Health Tech & Medtech

About BrosMed Medical

Founded in March 2012 by Benny Lee and Thomas Dong, BrosMed Medical is a developer and manufacturer of medical devices for interventional procedures. The company is headquartered in Dongguan, China, and has established itself as a multinational entity with four R&D centers and three manufacturing sites across China, Europe, and the Asia-Pacific region. BrosMed focuses on creating high-performance devices for minimally invasive surgeries, primarily serving interventional cardiologists, radiologists, and vascular surgeons.

The company's business model revolves around providing comprehensive solutions, from initial design and development to manufacturing and global distribution. BrosMed engages in both direct sales and OEM/ODM partnerships, leveraging its extensive manufacturing capacity—over 3 million balloon catheters annually—and a robust supply chain. This vertically integrated approach allows the firm to manage quality and costs effectively. The company's revenue is generated through the sale of its wide range of medical devices across more than 100 countries. A significant milestone was achieved on July 27, 2020, when BrosMed secured an undisclosed amount in a Series C funding round led by Hillhouse, with participation from other investors like Cathay Capital and Cowin Capital.

BrosMed's product portfolio is extensive, covering cardiovascular intervention, peripheral intervention, and neurovascular intervention. Key products include a variety of balloon dilatation catheters such as the Artimes Semi-Compliance and Apollo High-Pressure coronary catheters, the Conger Hydrophilic Guidewire, and the FreePath Catheter Sheath Introducer. The company also offers accessories like inflation devices, Y connector sets, and manifolds. A notable product is the RevoEdge High-Pressure Coronary Cutting Balloon, which has received the CE mark under the European Medical Device Regulation (MDR). BrosMed maintains compliance with global regulatory standards, including ISO 13485, QSR820, and cGMP, ensuring its products meet international safety and efficacy requirements.

Source: Dealroom company data

At a glance

Status
Operational
Employees
87
Open positions
2
Dealroom signal
57.5/100
Industry
Health
Sub-industry
Medical Devices
Sector
Surgery, Cardiology and cardiovascular, Catheters, Hard Tech, DT and LS, science-based
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Apr 2021
Capital deployed
$20M
Preferred round
SERIES B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jun 2025 $28M $110M River Head Capital · Singularity Capital · Mirae Asset Venture Investment · IDG Capital ↗
SERIES COther financing Jul 2020 $28M $110M NLVC · Hillhouse Capital · Cathay Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

BrosMed Medical website traffic

Latest recorded traffic for BrosMed Medical is 2.7K monthly website visits, down 37.2% over the last three months. BrosMed Medical's team grew 16% over the past year.

Latest monthly visits2.7K 3-month web change-37.2% 1-year team growth+16%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BrosMed Medical in the Dongguan ecosystem

Live from Dealroom

The BrosMed Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See BrosMed Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.